TY - JOUR T1 - On the Role of Artificial Intelligence in Medical Imaging of COVID-19 JF - medRxiv DO - 10.1101/2020.09.02.20187096 SP - 2020.09.02.20187096 AU - Jannis Born AU - David Beymer AU - Deepta Rajan AU - Adam Coy AU - Vandana V. Mukherjee AU - Matteo Manica AU - Prasanth Prasanna AU - Deddeh Ballah AU - Michal Guindy AU - Dorith Shaham AU - Pallav L. Shah AU - Emmanouil Karteris AU - Jan L. Robertus AU - Maria Gabrani AU - Michal Rosen-Zvi Y1 - 2021/01/01 UR - http://medrxiv.org/content/early/2021/03/30/2020.09.02.20187096.abstract N2 - The global COVID-19 pandemic has accelerated the development of numerous digital technologies in medicine from telemedicine to remote monitoring. Concurrently, the pandemic has resulted in huge pressures on healthcare systems. Medical imaging (MI) from chest radiographs to computed tomography and ultrasound of the thorax have played an important role in the diagnosis and management of the coronavirus infection.We conducted the, to date, largest systematic review of the literature addressing the utility of Artificial Intelligence (AI) in MI for COVID-19 management. Through keyword matching on PubMed and preprint servers, including arXiv, bioRxiv and medRxiv, 463 papers were selected for a meta-analysis, with manual reviews to assess the clinical relevance of AI solutions. Further, we evaluated the maturity of the papers based on five criteria assessing the state of the field: peer-review, patient dataset size and origin, algorithmic complexity, experimental rigor and clinical deployment.In 2020, we identified 4977 papers on MI in COVID-19, of which 872 mentioned the term AI. 2039 papers of the 4977 were specific to imaging modalities with a majority of 83.8% focusing on CT, while 10% involved CXR and 6.2% used LUS. Meanwhile, the AI literature predominantly analyzed CXR data (49.7%), with 38.7% using CT and 1.5% LUS. Only a small portion of the papers were judged as mature (2.7 %). 71.9% of AI papers centered on disease detection.This review evidences a disparity between clinicians and the AI community, both in the focus on imaging modalities and performed tasks. Therefore, in order to develop clinically relevant AI solutions, rigorously validated on large-scale patient data, we foresee a need for improved collaboration between the two communities ensuring optimal outcomes and allocation of resources. AI may aid clinicians and radiologists by providing better tools for localization and quantification of disease features and changes thereof, and, with integration of clinical data, may provide better diagnostic performance and prognostic value.Competing Interest StatementThe authors have declared no competing interest.Funding StatementNone.Author DeclarationsI confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.YesThe details of the IRB/oversight body that provided approval or exemption for the research described are given below:No clinical data was obtained.All necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived.YesI understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).YesI have followed all appropriate research reporting guidelines and uploaded the relevant EQUATOR Network research reporting checklist(s) and other pertinent material as supplementary files, if applicable.YesNo clinical data was used.ACR(American College of Radiology)AI(Artificial Intelligence)CT(Computed Tomography)CXR(Chest Radiographs)DL(Deep Learning)US(Ultrasound)LUS(Lung Ultrasound)MI(Medical Imaging)PRISMA(Preferred Reporting Items for Systematic Reviews and Meta-Analyses)RT-PCR(Reverse Transcriptase Polymerase Chain reaction) ER -